Pharmacists’ role in addressing opioid abuse, addiction, and diversion

Abstract Objective To review the scope of the problem of opioid misuse; explore pharmacists’ roles and responsibilities regarding opioid use; discuss existing laws, guidelines, and regulations governing opioid management; identify potential patient and practice management strategies to address opioi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Pharmacists Association 2014, Vol.54 (1), p.e5-e15
1. Verfasser: American Pharmacists Association
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Objective To review the scope of the problem of opioid misuse; explore pharmacists’ roles and responsibilities regarding opioid use; discuss existing laws, guidelines, and regulations governing opioid management; identify potential patient and practice management strategies to address opioid abuse; and disseminate leader insights on these issues. Data sources Information presented at a conference convened by the American Pharmacists Association (Pharmacists’ Role in Addressing Opioid Abuse, Addiction, and Diversion; held November 15, 2012) and discussed in conference workgroups, as well as related information from the literature. Summary Opioid misuse, abuse, and diversion has grown dramatically since the early 1990s and affects public health considerably. In 2011, more individuals died from drug overdoses than from motor vehicle accidents. Strategies are available that pharmacists can use to reduce the likelihood of opioid misuse, abuse, and diversion while minimizing the impact on legitimate pain management efforts. These strategies and tools can be used to support (1) the assessment of prescriptions that are presented for opioid medications, (2) the management of patients receiving opioids, and (3) follow-up options when misuse, abuse, or diversion has been identified. Conclusion Implementation of systems and processes that support pharmacist management of opioid-related issues under financially viable business models would create a number of opportunities to improve patient care.
ISSN:1544-3191
1544-3450
DOI:10.1331/JAPhA.2014.13101